Form 8-K - Current report:
SEC Accession No. 0001023024-08-000006
Filing Date
2008-04-21
Accepted
2008-04-21 16:55:42
Documents
2
Period of Report
2008-04-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8K FOR LEASE AMENDMENT 2008 leaseamendment2008.htm 8-K 29191
2 LEASE AMENDMENT exhibit10w1.htm EX-10.1 43732
  Complete submission text file 0001023024-08-000006.txt   74565
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 08767408
SIC: 2836 Biological Products, (No Diagnostic Substances)